About Us
At Crucial Innovations Corp (CINV), we are establishing a new standard for cultivating high-quality cannabis-based products for medicinal use (CBPMs) and enhancing quality throughout the global supply chain.
Our Vertically Integrated Approach
At CINV, we’re dedicated to providing patients with consistent, effective medical cannabis. We operate from a SAHPRA-licensed, GMP-accredited cultivation facility in the Western Cape, South Africa.
This indoor setup allows us to precisely control the growing environment, resulting in high-quality flower and a reliable yield. Currently, we produce 50 kg every 8 weeks, and we’re excited about an upcoming expansion that will boost our capacity to 1.7 tons of dried flower per year from this facility.
Genetics Cloning
We also operate Ember Pharms, a 17,000 sqm GMP-accredited facility in the Free State Province, South Africa. Here, we focus on cloning our genetics in our licensed nursery, advancing research and development, and managing commercial cultivation and processing to serve the UK market.
Our Mission
To expertly navigate the power of medical cannabis, offering a seamless journey from seed to healing.
Our commitment is to provide access to high-quality, safe CBPM treatments, ensuring they reach patients through licensed clinics and dispensaries. By harmonising nature’s healing power with our stringent regulatory and operating standards, CINV is not just offering medicine; we’re working on building a new paradigm of trust and efficacy in the medicinal cannabis industry.
Our Vision
A future where we are all empowered to drive our own healthcare journey
We dream of a world where healthcare is fundamentally reoriented. We want patients to be connected to the healing power of nature through our seamless and integrated network of cultivation, distribution, and care.
The future we envisage is not just a service, but a synergistic ecosystem that evolves and adapts – always putting the patient first.
Meet our team
Contact us today to learn more about our life-changing medicinal cannabis products and patient-centered services.
JP Doran
CEO, CINV
Timothy Ambrose
Chairman, CINV
Darlington Mazvidza
CFO, CINV
Bernard Pieters
COO, Ember Pharms
Chris Ioannou
Head of Cultivation, CINV
Our cultivation techniques produce premium cannabis flower with remarkable structure, yields, THC levels, and terpene profiles.
Through our exceptional genetics and strategic alliances, we are poised to supply the pharmaceutical industry with unparalleled GMP- Flower and GMP-Oil.
